ArticleJournal of clinical hypertension (Greenwich, Conn.)2022

Efficacy of angiotensin receptor neprilysin inhibitor in Asian patients with refractory hypertension.

Wanjing Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.